Immunology and Microbiology
Immunity
100%
Neoantigen
67%
Immunotherapy
65%
T Cell
64%
Protein RNA Binding
55%
Myeloid
46%
Cytotoxic T-Cell
39%
Programmed Death-Ligand 1
28%
Cancer Immunotherapy
26%
T-Helper Cell
26%
Immunoediting
24%
Tumor Cell
24%
Immune Checkpoint Blockade
23%
Tumor Antigen
23%
Immune-Related Gene
22%
Macrophage
20%
Cytokine
19%
Gene Expression
17%
Immune Response
17%
CTLA-4
17%
CX3CR1
15%
Tumor Vaccine
14%
Gene Control
13%
Cytokine Production
13%
Transcription Factor GATA 3
13%
Immune Escape
13%
Tumor-Associated Macrophage
12%
Immune System
12%
Interleukin 6
12%
Knockout Mouse
12%
CD4
12%
Upregulation
11%
Tumor Immunity
11%
Interleukin 17
11%
Major Histocompatibility Complex
11%
Host Cell
11%
Dendritic Cell
11%
Intravenous Immunoglobulin
11%
CD5
11%
Experimental Autoimmune Encephalomyelitis
11%
Homeostasis
11%
Interleukin 2
11%
Angiogenesis
11%
Gene Dosage
11%
Effector Cell
11%
CD47
11%
Adoptive Immunity
11%
Th17 Cell
8%
RNA Sequence
8%
Cancer Cell
8%
Keyphrases
RNA-binding Protein HuR
47%
Neoantigen
40%
CD4+ T Cells
33%
Tumor
33%
Cancer Immunosurveillance
25%
Anticancer Immune Response
25%
High-dimensional Analysis
22%
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
22%
Immune Checkpoint Therapy
22%
T Cells
22%
RNA-binding Protein
20%
CD8+ T Cells
20%
Tumor Cells
19%
Post-transcriptional Gene Regulation
19%
Tumor Antigen
18%
Cancer Immunotherapy
17%
Programmed Death-ligand 1 (PD-L1)
17%
Conditional Knockout
16%
MiRNA Target
13%
Cytokine Production
13%
MicroRNA
13%
Th2 Differentiation
13%
Personalized Cancer Therapy
13%
Tumor Neoantigens
13%
Immune Escape
13%
Inducible Nitric Oxide Synthase
12%
BHLHE40
12%
CD4+
12%
Steady State
12%
RNA Immunoprecipitation
12%
Knock-in Mouse Model
12%
Overexpression
12%
Recurrent Incisional Hernia
11%
T Cell Immunity
11%
Interleukin-17 (IL-17)
11%
Ribonucleoprotein Complex
11%
Tumor Immunity
11%
Transcriptomics
11%
Protein Components
11%
Scientific Advisory Board
11%
Host Cell
11%
Triple-negative Breast Cancer
11%
Cell-free Extract
11%
Gene Set
11%
PD-L1 Expression
11%
Colorectal Cancer
11%
MHC Class II
11%
Immunotherapy Response
11%
Cancer-related
11%
Transcriptional Program
11%
Biochemistry, Genetics and Molecular Biology
RNA-binding Protein
43%
T Cell
39%
RNA
34%
Immunity
28%
Messenger RNA
26%
Gene Expression
22%
Immune-Related Gene
22%
Immune Checkpoints
22%
Tumor Progression
19%
Transcriptomics
16%
Genomics
14%
Immunoprecipitation
13%
CTLA-4
13%
Estrogen Receptor
13%
MicroRNA
13%
Ribonucleoprotein
12%
Cell Extract
11%
Cytokine
11%
CD4
11%
GATA3
11%
Cancer Immunotherapy
11%
Angiogenesis
11%
Myeloid
11%
CX3CR1
11%
Steady State
8%
Tumor Rejection
7%
Tumor Antigen
7%
PD-L1
6%
Cell Activation
6%
Gene Control
6%
Bioinformatics
5%
RNA Sequence
5%
Pan-cancer
5%
Tamsulosin
5%